Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Zinc × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3 Tumor-Agnostic 2 Other hematologic neoplasm 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Interventions

Temozolomide 558 Radiotherapy 370 Bevacizumab 229 Magnetic Resonance Spectroscopy 203 Cyclophosphamide 157 Radiosurgery 150 Carboplatin 140 Radiation 114 Etoposide 114 Irinotecan 104 Vincristine 97 Cisplatin 86 Filgrastim 83 Specimen Handling 80 pembrolizumab 79 Nivolumab 75 Lomustine 75 Surgical Procedures, Operative 71 Topotecan 63 Melphalan 52 sargramostim 51 Radiotherapy, Intensity-Modulated 51 Carmustine 51 Isotretinoin 48 Granulocyte Colony-Stimulating Factor 47 Doxorubicin 47 Chemotherapy, Adjuvant 46 Peripheral Blood Stem Cell Transplantation 45 Erlotinib Hydrochloride 44 Blood Specimen Collection 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04488783 2020-07-28

Potentiation of Chemotherapy in Brain Tumors by Zinc

Sheba Medical Center

Phase NA Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡